The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
Published version of a preprint
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, sequencing data of SARS-CoV-2 from patients revealed persistent accumulation of new mutations over the last two years of the Covid19 pandemic, leading to the emergence of new viral strains that can be more transmissible or virulent5,6 or evade vaccines7–9.”
From The roles of APOBEC-mediated RNA editing in SARS-CoV-2 mutations, replication and fitness (2022) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2034577 · Cited by 14,592 · cited 2×
“Both of these vaccines demonstrated >94% efficacy at preventing coronavirus disease 2019 (COVID-19) in phase III clinical studies performed in late 2020 in multiple countries (Polack et al. 2020; Baden et al. 2021).”
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Baden, L. R., El Sahly, H. M., Essink, B., Kotloff, K., Frey, S., Novak, R., Diemert, D., Spector, S. A., Rouphael, N., Creech, C. B., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2035389 · Cited by 10,119
Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Hengartner, N., Giorgi, E. E., Bhattacharya, T., Foley, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.043 · Cited by 4,281
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7
Wang, P., Nair, M. S., Liu, L., Iketani, S., Luo, Y., Guo, Y., Wang, M., Yu, J., Zhang, B., Kwong, P. D., et al. (2021) · Nature · doi:10.1038/s41586-021-03398-2 · Cited by 2,312
Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity
Cantuti-Castelvetri, L., Ojha, R., Pedro, L. D., Djannatian, M., Franz, J., Kuivanen, S., van der Meer, F., Kallio, K., Kaya, T., Anastasina, M., et al. (2020) · Science · doi:10.1126/science.abd2985 · Cited by 1,925
Human neutralizing antibodies elicited by SARS-CoV-2 infection
Ju, B., Zhang, Q., Ge, J., Wang, R., Sun, J., Ge, X., Yu, J., Shan, S., Zhou, B., Song, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2380-z · Cited by 1,667 · cited 4×
“…now demonstrated a close correlation between neutralization titers measured against pseudovirus and live SARS-CoV-2 cultures (Wang et al., 2020; Ju et al., 2020; Pinto et al., 2020; Yang et al., 2020; Moore et al., 2004; Crawford et al., 2020; Riepler et al., 2020), it is unclear what impact…”
InfluentialSpike mutation D614G alters SARS-CoV-2 fitness
Plante, J. A., Liu, Y., Liu, J., Xia, H., Johnson, B. A., Lokugamage, K. G., Zhang, X., Muruato, A. E., Zou, J., Fontes-Garfias, C. R., et al. (2021) · Nature · doi:10.1038/s41586-020-2895-3 · Cited by 1,558
Baum, A., Fulton, B. O., Wloga, E., Copin, R., Pascal, K. E., Russo, V., Giordano, S., Lanza, K., Negron, N., Ni, M., et al. (2020) · Science · doi:10.1126/science.abd0831 · Cited by 1,253
Greaney, A. J., Loes, A. N., Crawford, K. H. D., Starr, T. N., Malone, K. D., Chu, H. Y., & Bloom, J. D. (2021) · doi:10.1101/2020.12.31.425021 · Cited by 1,178 · cited 2×
“The P.2. variant, which contains an E484K mutation within the RBD region, was capable of significantly reducing neutralization potency of fully vaccinated individuals, in line with what has been suggested by deep mutational scanning (Greaney et al., 2021a; Jangra et al., 2021).”
Greaney, A. J., Loes, A. N., Crawford, K. H. D., Starr, T. N., Malone, K. D., Chu, H. Y., & Bloom, J. D. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.02.003 · Cited by 1,178
Flagged first, then by citations
Research works printed but not linked: 29
- "AZD1222 Vaccine Met Primary Efficacy Endpoint in Preventing COVID-19." 2020. November 23, 2020. https://www.astrazeneca.com/media-centre/press- releases/2020/azd1222hlr.html.
- Crawford, Katharine H. D., Rachel Eguia, Adam S. Dingens, Andrea N. Loes, Keara D. Malone, Caitlin R. Wolf, Helen Y. Chu, et al. 2020. "Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays." Viruses 12 (5). https://doi.org/10.3390/v12050513. Faria et al. 2021. "Genomic Characterisation of an Emergent SARS-CoV-2 Lineage in Manaus: Preliminary Findings." January 12, 2021. https://virological.org/t/genomic- characterisation-of-an-emergent-sars-cov-2-lineage-in-manaus-preliminary-findings/586. · DOI
- Galloway, Summer E., Prabasaj Paul, Duncan R. MacCannell, Michael A. Johansson, John T. Brooks, Adam MacNeil, Rachel B. Slayton, et al. 2021. "Emergence of SARS-CoV-2 B.1.1.7 Lineage - United States, December 29, 2020-January 12, 2021." MMWR. Morbidity and Mortality Weekly Report 70 (3): 95–99.
- Garcia-Beltran, Wilfredo F., Evan C. Lam, Michael G. Astudillo, Diane Yang, Tyler E. Miller, Jared Feldman, Blake M. Hauser, et al. 2021. "COVID-19-Neutralizing Antibodies Predict Disease Severity and Survival." Cell 184 (2): 476–88.e11.
- The copyright holder for this preprint this version posted March 12, 2021. ; https://doi.org/10.1101/2021.02.14.21251704doi: medRxiv preprint http://paperpile.com/b/hwn56Z/HIfBd http://paperpile.com/b/hwn56Z/HIfBd https://www.astrazeneca.com/media-centre/press-releases/2020/azd1222hlr.html https://www.astrazeneca.com/media-centre/press-releases/2020/azd1222hlr.html http://paperpile.com/b/hwn56Z/HIfBd http://paperpile.com/b/hwn56Z/9fqtK http://paperpile.com/b/hwn56Z/9fqtK http://paperpile.com/b/hwn56Z/9fqtK http://paperpile.com/b/hwn56Z/9fqtK http://paperpile.com/b/hwn56Z/42Kr http://paperpile.com/b/hwn56Z/42Kr http://paperpile.com/b/hwn56Z/42Kr http://paperpile.com/b/hwn56Z/42Kr http://paperpile.com/b/hwn56Z/42Kr http://paperpile.com/b/hwn56Z/42Kr http://paperpile.com/b/hwn56Z/AXK7 http://paperpile.com/b/hwn56Z/AXK7 http://paperpile.com/b/hwn56Z/AXK7 http://paperpile.com/b/hwn56Z/AXK7 http://paperpile.com/b/hwn56Z/AXK7 http://paperpile.com/b/hwn56Z/lts5N http://paperpile.com/b/hwn56Z/lts5N http://paperpile.com/b/hwn56Z/lts5N http://paperpile.com/b/hwn56Z/lts5N http://paperpile.com/b/hwn56Z/lts5N http://paperpile.com/b/hwn56Z/dg29i https://www.raps.org/news-and-articles/news-articles/2020/3/covid-19-vaccine-tracker https://www.raps.org/news-and-articles/news-articles/2020/3/covid-19-vaccine-tracker http://paperpile.com/b/hwn56Z/dg29i http://paperpile.com/b/hwn56Z/qb1Q http://paperpile.com/b/hwn56Z/qb1Q http://paperpile.com/b/hwn56Z/qb1Q http://paperpile.com/b/hwn56Z/qb1Q http://paperpile.com/b/hwn56Z/qb1Q http://paperpile.com/b/hwn56Z/qb1Q http://dx.doi.org/10.3390/v12050513 http://paperpile.com/b/hwn56Z/qb1Q http://paperpile.com/b/hwn56Z/CvSS http://paperpile.com/b/hwn56Z/CvSS https://virological.org/t/genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-manaus-preliminary-findings/586 https://virological.org/t/genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-manaus-preliminary-findings/586 http://paperpile.com/b/hwn56Z/CvSS http://paperpile.com/b/hwn56Z/6LIqX http://paperpile.com/b/hwn56Z/6LIqX http://paperpile.com/b/hwn56Z/6LIqX http://paperpile.com/b/hwn56Z/6LIqX http://paperpile.com/b/hwn56Z/6LIqX http://paperpile.com/b/hwn56Z/6LIqX http://paperpile.com/b/hwn56Z/h747H http://paperpile.com/b/hwn56Z/h747H http://paperpile.com/b/hwn56Z/h747H http://paperpile.com/b/hwn56Z/h747H http://paperpile.com/b/hwn56Z/h747H http://paperpile.com/b/hwn56Z/tbJYp http://paperpile.com/b/hwn56Z/tbJYp http://paperpile.com/b/hwn56Z/tbJYp http://paperpile.com/b/hwn56Z/tbJYp http://paperpile.com/b/hwn56Z/tbJYp http://paperpile.com/b/hwn56Z/tbJYp http://paperpile.com/b/hwn56Z/tbJYp http://dx.doi.org/10.1101/2020.12.31.425021 http://paperpile.com/b/hwn56Z/tbJYp http://paperpile.com/b/hwn56Z/6QEPd http://paperpile.com/b/hwn56Z/6QEPd http://paperpile.com/b/hwn56Z/6QEPd http://paperpile.com/b/hwn56Z/6QEPd http://paperpile.com/b/hwn56Z/6QEPd http://paperpile.com/b/hwn56Z/6QEPd http://dx.doi.org/10.1101/2020.09.10.292078 http://paperpile.com/b/hwn56Z/6QEPd http://paperpile.com/b/hwn56Z/EpA5 http://paperpile.com/b/hwn56Z/EpA5 http://paperpile.com/b/hwn56Z/EpA5 https://www.statnews.com/2021/02/24/new-data-shed-light-on-efficacy-of-jjs-single-dose-vaccine-against-covid-19/ https://www.statnews.com/2021/02/24/new-data-shed-light-on-efficacy-of-jjs-single-dose-vaccine-against-covid-19/ http://paperpile.com/b/hwn56Z/EpA5 http://paperpile.com/b/hwn56Z/Kjw1 http://paperpile.com/b/hwn56Z/Kjw1 http://paperpile.com/b/hwn56Z/Kjw1 http://paperpile.com/b/hwn56Z/Kjw1 http://paperpile.com/b/hwn56Z/Kjw1 https://doi.org/10.1101/2021.02.14.21251704 http://creativecommons.org/licenses/by-nc-nd/4.0/ · DOI
- Dinnon 3rd, Sarah R. Leist, et al. 2020. "SARS-CoV-2 D614G Variant Exhibits Efficient Replication Ex Vivo and Transmission in Vivo." Science 370 (6523): 1464–68.
- Hu, Jie, Pai Peng, Kai Wang, Bei-Zhong Liu, Liang Fang, Fei-Yang Luo, Ai-Shun Jin, Ni Tang, and Ai-Long Huang. 2021. "Emerging SARS-CoV-2 Variants Reduce Neutralization Sensitivity to Convalescent Sera and Monoclonal Antibodies." Cold Spring Harbor Laboratory. https://doi.org/10.1101/2021.01.22.427749. · DOI
- Jangra, Sonia, Chengjin Ye, Raveen Rathnasinghe, Daniel Stadlbauer, Florian Krammer, Viviana Simon, Luis Martinez-Sobrido, Adolfo Garcia-Sastre, and Michael Schotsaert. 2021. "The E484K Mutation in the SARS-CoV-2 Spike Protein Reduces but Does Not Abolish Neutralizing Activity of Human Convalescent and Post-Vaccination Sera." medRxiv : The Preprint Server for Health Sciences, January. https://doi.org/10.1101/2021.01.26.21250543. · DOI
- Le Bert, Nina, Anthony T. Tan, Kamini Kunasegaran, Christine Y. L. Tham, Morteza Hafezi, Adeline Chia, Melissa Hui Yen Chng, et al. 2020. "SARS-CoV-2-Specific T Cell Immunity in Cases of COVID-19 and SARS, and Uninfected Controls." Nature 584 (7821): 457–62.
- Legros, Vincent, Solène Denolly, Manon Vogrig, Bertrand Boson, Eglantine Siret, Josselin Rigaill, Sylvie Pillet, et al. 2021. "A Longitudinal Study of SARS-CoV-2-Infected Patients Reveals a High Correlation between Neutralizing Antibodies and COVID-19 Severity." Cellular & Molecular Immunology 18 (2): 318–27.
- Lemieux, Jacob, Katherine J. Siddle, Bennett M. Shaw, Christine Loreth, Stephen Schaffner, Adrianne Gladden-Young, Gordon Adams, et al. 2020. "Phylogenetic Analysis of SARS- CoV-2 in the Boston Area Highlights the Role of Recurrent Importation and Superspreading Events." medRxiv : The Preprint Server for Health Sciences, August. https://doi.org/10.1101/2020.08.23.20178236. · DOI
- Liu, Haolin, Qianqian Zhang, Pengcheng Wei, Zhongzhou Chen, Katja Aviszus, John Yang, Walter Downing, et al. 2021. "The Basis of a More Contagious 501Y.V1 Variant of SARS- COV-2." Cold Spring Harbor Laboratory. https://doi.org/10.1101/2021.02.02.428884. · DOI
- Moore, Michael J., Tatyana Dorfman, Wenhui Li, Swee Kee Wong, Yanhan Li, Jens H. Kuhn, James Coderre, et al. 2004. "Retroviruses Pseudotyped with the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Efficiently Infect Cells Expressing Angiotensin- Converting Enzyme 2." Journal of Virology 78 (19): 10628–35.
- The copyright holder for this preprint this version posted March 12, 2021. ; https://doi.org/10.1101/2021.02.14.21251704doi: medRxiv preprint http://paperpile.com/b/hwn56Z/Kjw1 http://paperpile.com/b/hwn56Z/Rf3z1 http://paperpile.com/b/hwn56Z/Rf3z1 http://paperpile.com/b/hwn56Z/Rf3z1 http://paperpile.com/b/hwn56Z/Rf3z1 http://paperpile.com/b/hwn56Z/Rf3z1 http://paperpile.com/b/hwn56Z/8xEEs http://paperpile.com/b/hwn56Z/8xEEs http://paperpile.com/b/hwn56Z/8xEEs http://paperpile.com/b/hwn56Z/8xEEs http://paperpile.com/b/hwn56Z/8xEEs http://paperpile.com/b/hwn56Z/8xEEs http://dx.doi.org/10.1101/2021.01.22.427749 http://paperpile.com/b/hwn56Z/8xEEs http://paperpile.com/b/hwn56Z/B95jI http://paperpile.com/b/hwn56Z/B95jI http://paperpile.com/b/hwn56Z/B95jI http://paperpile.com/b/hwn56Z/B95jI http://paperpile.com/b/hwn56Z/B95jI http://paperpile.com/b/hwn56Z/B95jI http://paperpile.com/b/hwn56Z/B95jI http://paperpile.com/b/hwn56Z/B95jI http://dx.doi.org/10.1101/2021.01.26.21250543 http://paperpile.com/b/hwn56Z/B95jI http://paperpile.com/b/hwn56Z/c7qJ http://paperpile.com/b/hwn56Z/c7qJ http://paperpile.com/b/hwn56Z/c7qJ http://paperpile.com/b/hwn56Z/c7qJ http://paperpile.com/b/hwn56Z/c7qJ http://paperpile.com/b/hwn56Z/3MDwa http://paperpile.com/b/hwn56Z/3MDwa http://paperpile.com/b/hwn56Z/3MDwa http://paperpile.com/b/hwn56Z/3MDwa http://paperpile.com/b/hwn56Z/3MDwa http://paperpile.com/b/hwn56Z/3MDwa http://paperpile.com/b/hwn56Z/UinE7 http://paperpile.com/b/hwn56Z/UinE7 http://paperpile.com/b/hwn56Z/UinE7 http://paperpile.com/b/hwn56Z/UinE7 http://paperpile.com/b/hwn56Z/UinE7 http://paperpile.com/b/hwn56Z/V5QUl http://paperpile.com/b/hwn56Z/V5QUl http://paperpile.com/b/hwn56Z/V5QUl http://paperpile.com/b/hwn56Z/V5QUl http://paperpile.com/b/hwn56Z/V5QUl http://paperpile.com/b/hwn56Z/V5QUl http://paperpile.com/b/hwn56Z/qkBP5 http://paperpile.com/b/hwn56Z/qkBP5 http://paperpile.com/b/hwn56Z/qkBP5 http://paperpile.com/b/hwn56Z/qkBP5 http://paperpile.com/b/hwn56Z/qkBP5 http://paperpile.com/b/hwn56Z/qkBP5 http://paperpile.com/b/hwn56Z/qkBP5 http://dx.doi.org/10.1101/2020.08.23.20178236 http://paperpile.com/b/hwn56Z/qkBP5 http://paperpile.com/b/hwn56Z/CiVcj http://paperpile.com/b/hwn56Z/CiVcj http://paperpile.com/b/hwn56Z/CiVcj http://paperpile.com/b/hwn56Z/CiVcj http://paperpile.com/b/hwn56Z/CiVcj http://dx.doi.org/10.1101/2021.02.02.428884 http://paperpile.com/b/hwn56Z/CiVcj http://paperpile.com/b/hwn56Z/szOdY http://paperpile.com/b/hwn56Z/szOdY https://www.the-scientist.com/news-opinion/moderna-developing-booster-shot-for-new-virus-variant-b-1-351-68384 https://www.the-scientist.com/news-opinion/moderna-developing-booster-shot-for-new-virus-variant-b-1-351-68384 http://paperpile.com/b/hwn56Z/szOdY http://paperpile.com/b/hwn56Z/P2rT http://paperpile.com/b/hwn56Z/P2rT http://paperpile.com/b/hwn56Z/P2rT http://paperpile.com/b/hwn56Z/P2rT http://paperpile.com/b/hwn56Z/P2rT http://paperpile.com/b/hwn56Z/P2rT http://paperpile.com/b/hwn56Z/ReOyr http://paperpile.com/b/hwn56Z/ReOyr http://paperpile.com/b/hwn56Z/ReOyr http://paperpile.com/b/hwn56Z/ReOyr http://paperpile.com/b/hwn56Z/ReOyr http://paperpile.com/b/hwn56Z/ReOyr http://dx.doi.org/10.1126/science.abg6105 http://paperpile.com/b/hwn56Z/ReOyr http://paperpile.com/b/hwn56Z/PDnnN http://paperpile.com/b/hwn56Z/PDnnN https://virological.org/t/sars-cov-2-reinfection-by-the-new-variant-of-concern-voc-p-1-in-amazonas-brazil/596 https://virological.org/t/sars-cov-2-reinfection-by-the-new-variant-of-concern-voc-p-1-in-amazonas-brazil/596 http://paperpile.com/b/hwn56Z/PDnnN http://paperpile.com/b/hwn56Z/dyr9H https://doi.org/10.1101/2021.02.14.21251704 http://creativecommons.org/licenses/by-nc-nd/4.0/ · DOI
- Mendes, Renato Santana de Aguiar, Marta Giovanetti, and Bruno Solano de Freitas Souza. 2021. "Genomic Evidence of a Sars-Cov-2 Reinfection Case With E484K Spike Mutation in Brazil," January. https://doi.org/10.20944/preprints202101.0132.v1. · DOI
- Oude Munnink, Bas B., Reina S. Sikkema, David F. Nieuwenhuijse, Robert Jan Molenaar, Emmanuelle Munger, Richard Molenkamp, Arco van der Spek, et al. 2021. "Transmission of SARS-CoV-2 on Mink Farms between Humans and Mink and back to Humans." Science 371 (6525): 172–77.
- Paiva, Marcelo Henrique Santos, Duschinka Ribeiro Duarte Guedes, Cássia Docena, Matheus Filgueira Bezerra, Filipe Zimmer Dezordi, Laís Ceschini Machado, Larissa Krokovsky, et al. 2020. "Multiple Introductions Followed by Ongoing Community Spread of SARS-CoV-2 at One of the Largest Metropolitan Areas of Northeast Brazil." Viruses 12 (12). https://doi.org/10.3390/v12121414. · DOI
- Pinto, Dora, Young-Jun Park, Martina Beltramello, Alexandra C. Walls, M. Alejandra Tortorici, Siro Bianchi, Stefano Jaconi, et al. 2020. "Structural and Functional Analysis of a Potent Sarbecovirus Neutralizing Antibody." bioRxiv : The Preprint Server for Biology, April. https://doi.org/10.1101/2020.04.07.023903. · DOI · Paper page
- Rees-Spear, C., L. Muir, S. A. Griffith, J. Heaney, Y. Aldon, J. L. Snitselaar, P. Thomas, et al. 2021. "The Impact of Spike Mutations on SARS-CoV-2 Neutralization." Cold Spring Harbor Laboratory. https://doi.org/10.1101/2021.01.15.426849. Resende et al. 2021. "Spike E484K Mutation in the First SARS-CoV-2 Reinfection Case Confirmed in Brazil, 2020." January 10, 2021. https://virological.org/t/spike-e484k-mutation- in-the-first-sars-cov-2-reinfection-case-confirmed-in-brazil-2020/584. · DOI
- Santos, Jadson C., and Geraldo A. Passos. 2021. "The High Infectivity of SARS-CoV-2 B.1.1.7 Is Associated with Increased Interaction Force between Spike-ACE2 Caused by the Viral N501Y Mutation." Cold Spring Harbor Laboratory. https://doi.org/10.1101/2020.12.29.424708. · DOI
- Shen, Xiaoying, Haili Tang, Charlene McDanal, Kshitij Wagh, Will Fischer, James Theiler, Hyejin Yoon, et al. 2021. "SARS-CoV-2 Variant B.1.1.7 Is Susceptible to Neutralizing Antibodies Elicited by Ancestral Spike Vaccines." bioRxiv : The Preprint Server for Biology, January. https://doi.org/10.1101/2021.01.27.428516. · DOI
- Siebring-van Olst, Ellen, Christie Vermeulen, Renee X. de Menezes, Michael Howell, Egbert F. Smit, and Victor W. van Beusechem. 2013. "Affordable Luciferase Reporter Assay for Cell- Based High-Throughput Screening." Journal of Biomolecular Screening 18 (4): 453–61.
- "South Africa Suspends Use of AstraZeneca's COVID-19 Vaccine after It Fails to Clearly Stop Virus Variant." 2021. February 7, 2021. https://www.sciencemag.org/news/2021/02/south- africa-suspends-use-astrazenecas-covid-19-vaccine-after-it-fails-clearly-stop.
- Wang, Chunyan, Wentao Li, Dubravka Drabek, Nisreen M. A. Okba, Rien van Haperen, Albert D. M. E. Osterhaus, Frank J. M. van Kuppeveld, Bart L. Haagmans, Frank Grosveld, and Berend-Jan Bosch. 2020. "A Human Monoclonal Antibody Blocking SARS-CoV-2 Infection." Nature Communications 11 (1): 2251.
- Wu, Kai, Anne P. Werner, Juan I. Moliva, Matthew Koch, Angela Choi, Guillaume B. E. Stewart- Jones, Hamilton Bennett, et al. 2021. "mRNA-1273 Vaccine Induces Neutralizing Antibodies against Spike Mutants from Global SARS-CoV-2 Variants." bioRxiv : The Preprint Server for Biology, January. https://doi.org/10.1101/2021.01.25.427948. · DOI · Paper page
- Yurkovetskiy, Leonid, Xue Wang, Kristen E. Pascal, Christopher Tomkins-Tinch, Thomas P. Nyalile, Yetao Wang, Alina Baum, et al. 2020a. "Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant." Cell 183 (3): 739–51.e8.
- Yurkovetskiy, Leonid, Xue Wang, Kristen E. Pascal, Christopher Tomkins-Tinch, Thomas Nyalile, Yetao Wang, Alina Baum, et al. 2020b. "SARS-CoV-2 Spike Protein Variant D614G Increases Infectivity and Retains Sensitivity to Antibodies That Target the Receptor Binding Domain." bioRxiv : The Preprint Server for Biology, July. https://doi.org/10.1101/2020.07.04.187757. · DOI
- Zhou, Bin, Tran Thi Nhu Thao, Donata Hoffmann, Adriano Taddeo, Nadine Ebert, Fabien Labroussaa, Anne Pohlmann, et al. 2020. "SARS-CoV-2 Spike D614G Variant Confers Enhanced Replication and Transmissibility." bioRxiv : The Preprint Server for Biology, October. https://doi.org/10.1101/2020.10.27.357558. · DOI
- The copyright holder for this preprint this version posted March 12, 2021. ; https://doi.org/10.1101/2021.02.14.21251704doi: medRxiv preprint http://paperpile.com/b/hwn56Z/Och4 http://paperpile.com/b/hwn56Z/Och4 http://dx.doi.org/10.21203/rs.3.rs-226857/v1 http://paperpile.com/b/hwn56Z/Och4 http://paperpile.com/b/hwn56Z/u2ik http://paperpile.com/b/hwn56Z/u2ik https://www.sciencemag.org/news/2021/02/south-africa-suspends-use-astrazenecas-covid-19-vaccine-after-it-fails-clearly-stop https://www.sciencemag.org/news/2021/02/south-africa-suspends-use-astrazenecas-covid-19-vaccine-after-it-fails-clearly-stop http://paperpile.com/b/hwn56Z/u2ik http://paperpile.com/b/hwn56Z/ureSv http://paperpile.com/b/hwn56Z/ureSv http://paperpile.com/b/hwn56Z/ureSv http://paperpile.com/b/hwn56Z/ureSv http://paperpile.com/b/hwn56Z/ureSv http://paperpile.com/b/hwn56Z/Am82 http://paperpile.com/b/hwn56Z/Am82 http://paperpile.com/b/hwn56Z/Am82 http://paperpile.com/b/hwn56Z/Am82 http://paperpile.com/b/hwn56Z/Am82 http://paperpile.com/b/hwn56Z/Am82 http://paperpile.com/b/hwn56Z/JjMqB http://paperpile.com/b/hwn56Z/JjMqB http://paperpile.com/b/hwn56Z/JjMqB http://paperpile.com/b/hwn56Z/JjMqB http://paperpile.com/b/hwn56Z/JjMqB http://paperpile.com/b/hwn56Z/JjMqB http://dx.doi.org/10.1101/2021.01.25.428137 http://paperpile.com/b/hwn56Z/JjMqB http://paperpile.com/b/hwn56Z/ig3Ke http://paperpile.com/b/hwn56Z/ig3Ke http://paperpile.com/b/hwn56Z/ig3Ke http://paperpile.com/b/hwn56Z/ig3Ke http://paperpile.com/b/hwn56Z/ig3Ke http://paperpile.com/b/hwn56Z/ig3Ke http://dx.doi.org/10.1101/2021.01.18.427166 http://paperpile.com/b/hwn56Z/ig3Ke http://paperpile.com/b/hwn56Z/sZ2t8 http://paperpile.com/b/hwn56Z/sZ2t8 http://paperpile.com/b/hwn56Z/sZ2t8 http://paperpile.com/b/hwn56Z/sZ2t8 http://paperpile.com/b/hwn56Z/sZ2t8 http://paperpile.com/b/hwn56Z/sZ2t8 http://dx.doi.org/10.1101/2021.01.25.427948 http://paperpile.com/b/hwn56Z/sZ2t8 http://paperpile.com/b/hwn56Z/HyOk http://paperpile.com/b/hwn56Z/HyOk http://paperpile.com/b/hwn56Z/HyOk http://paperpile.com/b/hwn56Z/HyOk http://paperpile.com/b/hwn56Z/HyOk http://paperpile.com/b/hwn56Z/HyOk http://dx.doi.org/10.1016/j.bsheal.2020.08.004 http://paperpile.com/b/hwn56Z/HyOk http://paperpile.com/b/hwn56Z/3x4zP http://paperpile.com/b/hwn56Z/3x4zP http://paperpile.com/b/hwn56Z/3x4zP http://paperpile.com/b/hwn56Z/3x4zP http://paperpile.com/b/hwn56Z/3x4zP http://paperpile.com/b/hwn56Z/FPkvJ http://paperpile.com/b/hwn56Z/FPkvJ http://paperpile.com/b/hwn56Z/FPkvJ http://paperpile.com/b/hwn56Z/FPkvJ http://paperpile.com/b/hwn56Z/FPkvJ http://paperpile.com/b/hwn56Z/FPkvJ http://paperpile.com/b/hwn56Z/FPkvJ http://dx.doi.org/10.1101/2020.07.04.187757 http://paperpile.com/b/hwn56Z/FPkvJ http://paperpile.com/b/hwn56Z/G433S http://paperpile.com/b/hwn56Z/G433S http://paperpile.com/b/hwn56Z/G433S http://paperpile.com/b/hwn56Z/G433S http://paperpile.com/b/hwn56Z/G433S http://paperpile.com/b/hwn56Z/G433S http://dx.doi.org/10.1101/2020.10.27.357558 http://paperpile.com/b/hwn56Z/G433S https://doi.org/10.1101/2021.02.14.21251704 http://creativecommons.org/licenses/by-nc-nd/4.0/ · DOI
Cited by
Sorted by citations
SARS-CoV-2 variants, spike mutations and immune escape
Harvey, W. T., Carabelli, A. M., Jackson, B., Gupta, R. K., Thomson, E. C., Harrison, E. M., Ludden, C., Reeve, R., Rambaut, A., COVID-19 Genomics UK (COG-UK) Consortium, et al. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00573-0 · Cited by 3,528
Cele, S., Jackson, L., Khoury, D. S., Khan, K., Moyo-Gwete, T., Tegally, H., San, J. E., Cromer, D., Scheepers, C., Amoako, D., et al. (2021) · doi:10.1101/2021.12.08.21267417 · Cited by 1,333
Self-citationGoel, R. R., Apostolidis, S. A., Painter, M. M., Mathew, D., Pattekar, A., Kuthuru, O., Gouma, S., Hicks, P., Meng, W., Rosenfeld, A. M., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abi6950 · Cited by 655
Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma
Network for Genomic Surveillance in South Africa, Cele, S., COMMIT-KZN Team, Gazy, I., Jackson, L., Hwa, S.-H., Tegally, H., Lustig, G., Giandhari, J., Pillay, S., et al. (2021) · Nature · doi:10.1038/s41586-021-03471-w · Cited by 651
Self-citationSARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity
Motozono, C., Toyoda, M., Zahradnik, J., Saito, A., Nasser, H., Tan, T. S., Ngare, I., Kimura, I., Uriu, K., Kosugi, Y., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.06.006 · Cited by 586
Metadata
- Authors
- Garcia-Beltran, W. F., Lam, E. C., St. Denis, K., Nitido, A. D., Garcia, Z. H., Hauser, B. M., Feldman, J., Pavlovic, M. N., Gregory, D. J., Poznansky, M. C., Sigal, A., Schmidt, A. G., Iafrate, A. J., Naranbhai, V., & Balazs, A. B.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2021-04
- Volume
- 184
- Issue
- 9
- Pages
- 2523
- ISSN
- 0092-8674
- Cited by
- 243
- References
- 18
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
